Search

everythinglearnresearchcommunity

for

Search:↓

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Higher hair calcium to magnesium ratios and lower chromium levels in hair may indicate insulin resistance in Korean men.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Premature hair greying may indicate a higher risk of metabolic problems.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Metformin is less effective in men with early-onset hair loss.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.